BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4190268)

  • 1. [Behavior of tetanus antitoxin level in human serum following simultaneous prevention with tetanus immunoglobulin].
    Harrfeldt HP
    Langenbecks Arch Chir; 1969; 325():947-9. PubMed ID: 4190268
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status of preventive measures in tetanus].
    Eckmann L
    Langenbecks Arch Chir; 1969; 325():937-40. PubMed ID: 4190266
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of acute tetanus].
    Weis KH; Finger H; Rietbrock I; Koch KH
    Langenbecks Arch Chir; 1969; 325():952-4. PubMed ID: 4190269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human antitetanus gamma globulins].
    Herzog F; Gaiffe M; Badillet M
    Presse Med (1893); 1969 Feb; 77(6):207-8. PubMed ID: 4182144
    [No Abstract]   [Full Text] [Related]  

  • 5. Active-passive immunization of human subjects against tetanus using homologous gamma globulin.
    Matveev KI; Skurkovich SV; Bychenko BD; Kasparova EM; Konstantinova ND; Minaeva HL
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):246-51. PubMed ID: 4137523
    [No Abstract]   [Full Text] [Related]  

  • 6. The differences in immunizing capacity between various tetanus toxoids in active-passive immunization with human antitoxin.
    Cohen H; Peetoom F; van Ramshorst JD
    Prog Immunobiol Stand; 1970; 4():527-32. PubMed ID: 5482197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of tetanus].
    Falisevac J; Mravunac B; Ivesa-Petricević S; Hrabar A
    Lijec Vjesn; 1972 Jan; 94(1):13-20. PubMed ID: 5077211
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal tetanus despite immunization and protective antitoxin antibody.
    de Moraes-Pinto MI; Oruamabo RS; Igbagiri FP; Chan MC; Prado SM; Vancetto MD; Johnson PM; Hart CA
    J Infect Dis; 1995 Apr; 171(4):1076-7. PubMed ID: 7706800
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tetanus immune prophylaxis for the injured (author's transl)].
    Bundesvereinigung K
    Anaesthesist; 1973 Sep; 22(9):411-2. PubMed ID: 4762350
    [No Abstract]   [Full Text] [Related]  

  • 10. Human antitoxin in prophylaxis and treatment of tetanus.
    Med Lett Drugs Ther; 1965 Feb; 7(4):13-4. PubMed ID: 5831349
    [No Abstract]   [Full Text] [Related]  

  • 11. [The perspectives of improvement in tetanus prevention].
    Mateev KI; Sergeeva TI
    Vestn Akad Med Nauk SSSR; 1975; (4):84-90. PubMed ID: 1220372
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the problem of the use of homologous tetanus antitoxins in the treatment of severe tetanus: clinical and immunologic studies following treatment with human tetanus-hyperimmunoglobulin].
    Auerswald W; Brücke P; Kucher R; Marsoner F; Müller H; Seidl H; Steinbereithner K; Wagner E
    Wien Med Wochenschr; 1966 Mar; 116(11):229-35. PubMed ID: 4168478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tolerance and effectiveness of tetanus immunoglobulin with special reference to simultaneous prevention].
    Harrfeldt HP
    Dtsch Med Wochenschr; 1972 Mar; 97(10):364-8. PubMed ID: 5011481
    [No Abstract]   [Full Text] [Related]  

  • 14. Active immunization against tetanus in man. II. Combined active and passive prophylaxis with human tetanus immune globulin.
    Ullberg Olsson K; Eriksson E; Lundström R; Wiholm S
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):191-201. PubMed ID: 134538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological prevention of tetanus in hospitals: practical notes].
    Di Rocco P
    Ig Mod; 1970; 63(1):38-46. PubMed ID: 4098587
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal tetanus despite protective serum antitoxin concentration.
    Maselle SY; Matre R; Mbise R; Hofstad T
    FEMS Microbiol Immunol; 1991 Jun; 3(3):171-5. PubMed ID: 1878260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of antitoxin titer in the human serum during various active tetanus immunizations].
    Harrfeldt HP
    Dtsch Med Wochenschr; 1969 May; 94(21):1101-6. PubMed ID: 5769146
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetanus prophylaxis.
    Lancet; 1965 Nov; 2(7420):999-1000. PubMed ID: 4159223
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of human anti-tetanus hyperimmunoglobulin].
    Eckmann L
    Schweiz Med Wochenschr; 1970 Sep; 100(39):1656-7. PubMed ID: 4105250
    [No Abstract]   [Full Text] [Related]  

  • 20. Active immunization against tetanus in man. III. Antibody response to vaccine injections in the presence of therapeutic doses of human tetanus immune globulin. a record of five cases.
    Ullberg-Olsson K
    Eur Surg Res; 1975; 7(6):305-14. PubMed ID: 1183456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.